Further, USP15 is upregulated in several malignancies including breast, ovarian, gastric, and bladder cancers, but downregulated in around 25% of pancreatic cancer and 11% of glioblastoma, indicating that USP15 potentially has dual roles in promoting and suppressing tumors [5–10]. Here, USP15 is linked to urinary bladder cancer.